
About Medigus Ltd
Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 1999 and is headquartered in Omer, Israel. Address: No. 7A, Omer Industrial Park, Omer, Israel, 8496500
Medigus Ltd News and around…
Latest news about Medigus Ltd (MDGS) common stock and company :
On Tuesday, 123 stocks made new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by ...
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released update note on Medigus Limited (NASDAQ: MDGS). The update note includes information on the Medigus’ financial results, management commentary, recent developments, outlook, risks, and our revised valuation estimates. The update note is available here. Highlights from the note include: Investment in Deep Tech - In line with the compan
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing ...
Record Revenues of $10.1 million, up 1,805% over 202047% gross margin and 40% net margin$4 million net income for the full year, up from a net loss of $6.9 million in 2020 TEL AVIV, Israel, May 02, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, today reported financial results for the fiscal year ended December 31, 2021. Key Highlight
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed ...
Tel Aviv, Israel, April 25, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that ParaZero Ltd. (“ParaZero”), a privately held company engaged in drone technology with an innovative patented safety system for drones, of which Medigus has a 40 percent ownership stake, has signed an agreement with a leading global automotive manufacturer fo
New investment targets improving and optimizing the global water, oil, and gas transportation infrastructure through cutting-edge technology that reduces pump energy requirementsTel Aviv, Israel, April 13, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that it has signed an agreement to invest in ABI Energy Ltd. (ABI), a deep-tech compa
The results are consistent with a series of Polyrizon's previous successful tests in human coronavirus 229E and Influenza Virus H1N1Tel Aviv, Israel, April 05, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 37.03% of its share capital, presented pre-clinical data showing th
Leading drone company using ParaZero's SafeAir™ system is heading towards completing final regulatory process of type certification with the U.S. Federal Aviation Administration (FAA)Tel Aviv, Israel, April 04, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that ParaZero Ltd. ("ParaZero"), a privately held company engaged in drone techn
Medigus expects to consolidate Gix Internet’s financial results during 2022 Tel Aviv, Israel, March 31, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that its affiliate Gix Internet, (henceforth “Gix”) (41.56% owned by Medigus on a fully diluted basis) (TASE: GIX), a global marketing technology (MarTech) solutions company for online per
NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an update report on Medigus Ltd. (NASDAQ: MDGS). The update report includes detailed information on the Medigus’s business model, services, industry, valuation, management, and risks. The full update report is available here. Highlights from the report include: Strong Momentum in EV & Micro-Mobility Segment Targeting Growing Marke
ParaZero’s unique patented technology designed to prevent drone crashes and losses Tel Aviv, Israel, March 14, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that ParaZero Ltd. ("ParaZero"), a privately held company engaged in drone technology with an innovative patented safety system for drones, of which Medigus has a 40 percent owners
Israel-basedMedigus Ltd(NASDAQ: MDGS) and its wholly-owned subsidiary, Charging Robotics, havesigned ...
Charging Robotics signs LOI to complete reverse merger on OTC Markets Tel Aviv, Israel, March 11, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that the Company and its wholly owned subsidiary, Charging Robotics Ltd., signed a non-binding letter of intent for a planned securities exchange agreement with Fuel Doctor, Inc. (OTC: FDOC), a
NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Medigus Ltd. (NASDAQ:MDGS). The in-depth 22-page initiation report includes detailed information on the Medigus’s business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Large Market Opportunity Large Total Addressable Market
Tel Aviv, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Revoltz, an EV and wireless charging joint venture, of which Medigus owns 19.9% and which is operated through the Company’s wholly owned subsidiary, Charging Robotics Ltd., will start a pilot project at a new fully autonomous supermarket in Israel. As
Prof. Agmon-Levin serves as the Head of the Clinical Immunology, Angioedema and Allergy Unit, Lupus and Autoimmune Diseases Clinic at Sheba Medical Center - Tel HaShomer, Israel Tel Aviv, Israel, March 03, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd., a privately held company in which Medigus owns 37.03%, has
In less than a year, Revoltz designed, manufactured, presented and received first order for its first model "Porto," for the last mile delivery market Tel Aviv, Israel, March 01, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Revoltz, an EV and wireless charging joint venture of which Medigus owns 19.9%, and which is operated
Tel Aviv, Israel, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that its 47.69% owned subsidiary, Eventer Technologies Ltd. (“Eventer”), a developer of a technology platform enabling producers and venues to create virtual conferences and events including a smart ticketing solution, signed contracts with the Israel Gymnastics Federati
Gainers Revelation Biosciences (NASDAQ:REVB) stock moved upwards by 30.0% to $2.0 during Tuesday's after-market session. Today's ...
Benzinga is thrilled to announce the guest lineup for our next All Access show, sponsored by TiiCKER, set to air Friday, February 18 at ...
Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional InvestorsNEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on February 24, 2022. The conference, which is open to all retail and institutional investors, will consist of a series of twenty five
Tel Aviv, Israel, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that its wholly-owned subsidiary, Charging Robotics Ltd. and BGN Technologies, the technology transferred company of Ben-Gurion University signed an agreement to develop the next generation of Charging Robotics' wireless charging system for electric vehicles. Once
Tel Aviv, Israel, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that ParaZero Ltd. ("ParaZero"), a privately held company engaged in drone technology with an innovative patented safety system for drones, of which Medigus has a 40% ownership stake, confirmed that a drone carrying its ParaZero SafeAirTM system was granted the fir
Clearmind and Medigus, the investor, intend to form a joint venture in the field of food industry, based on Clearmind's unique psychedelics IPTORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTCMKTS: CMNDF) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, announced today it has signed an agreement f
The parties intend to form a joint venture in the food industry, based on Clearmind's unique psychedelics IPTel Aviv, Israel, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today the expansion of its healthcare activities by signing an investment agreement with Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTCMKTS: CMNDF), a psychede
Gainers Madrigal Pharmaceuticals (NASDAQ:MDGL) shares rose 14.9% to $64.8 during Monday's pre-market session. The ...
Gainers Biophytis (NASDAQ:BPTS) shares moved upwards by 37.54% to $8.5 during Monday's after-market session. The market value of ...
Gainers Medigus (NASDAQ:MDGS) shares moved upwards by 12.04% to $1.62 during Thursday's pre-market session. The ...
Medigus Ltd (MDGS) is a NASDAQ Common Stock listed in Common Stock, Healthcare, Medical Devices